How corticosteroids affect heart health in muscular dystrophy
Mechanisms of corticosteroids in dystrophic cardiomyopathy
This study is looking at a new steroid called vamorolone to see if it can help improve heart health in people with Duchenne and Becker muscular dystrophy, without the usual side effects of traditional steroids.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-10896474 on NIH RePORTER |
What this research studies
This research investigates the role of corticosteroids in treating heart conditions associated with muscular dystrophy, particularly focusing on Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy. The team has developed a new type of steroid, vamorolone, which has shown promise in reducing inflammation and protecting heart function without the typical side effects of traditional corticosteroids. Using animal models, the research aims to understand how these steroids interact with heart tissues and their potential to improve heart health in patients with these conditions. The findings could lead to better treatment options for individuals suffering from heart complications related to muscular dystrophy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Duchenne muscular dystrophy or Becker muscular dystrophy who experience heart-related issues.
Not a fit: Patients with other forms of muscular dystrophy or those without heart complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved heart health and reduced mortality for patients with muscular dystrophy.
How similar studies have performed: Previous research has shown success with corticosteroids in treating heart conditions in muscular dystrophy, making this approach promising.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Heier, Christopher Ryan — Virginia Commonwealth University
- Study coordinator: Heier, Christopher Ryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.